Researchers have identified a metabolically sensitive cell subtype in the eye's drainage system which shows early signs of ...
Single-cell transcriptomics identifies three discrete mouse trabecular meshwork subtypes and demonstrates that an Lmx1b glaucoma mutation drives mitochondrial dysfunction and elevated intraocular ...
Prostaglandin analogues, such as latanoprost and bimatoprost, are the go-to therapies for glaucoma therapy. They continue to ...
The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
Glaukos Corporation , an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that the U.
To yield the benefits of interventional glaucoma treatment, ophthalmologists need a roadmap for how to implement it, according to a speaker here. At the Hawaiian Eye 2026 meeting, Christine Funke, MD, ...
Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative ...
Glaucoma has long been treated as a plumbing problem of the eye, managed mainly by lowering pressure rather than protecting ...
Fourth quarter 2025 total revenue is expected to be in the range of $20.3 million to $20.4 million, an increase of 7% at the estimated midpoint compared to the prior year period.
This article is a part of CNN Underscored’s Guide to Age-Defying Beauty, a weeklong focus on the essential products, tips and tricks to enhance your glow at any age. We’ll be featuring editor-tested ...
For many people, the under-eye area yields a host of concerns, including dryness, fine lines, dark circles and puffiness. Since this particular area is one of the most sensitive parts of your body, ...
Caroline Igo (she/her/hers) was a wellness editor at CNET and holds Sleep Science Coach and Stress Management certificates from the Spencer Institute. She received her bachelor's degree in creative ...